Expert Review of Hematology

Papers
(The H4-Index of Expert Review of Hematology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
CD123-targeted therapy in acute myeloid leukemia51
What is the future of digital tools to help manage pain in sickle cell disease patients?50
Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia42
Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management42
Platelets: the point of interconnection among cancer, inflammation and cardiovascular diseases34
Do we need more guidance on thrombophilia testing? Challenges and special considerations31
Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOP26
Frequencies of glycosylphosphatidylinositol (GPI)-deficient cells using high-sensitivity flow cytometry as per the 2018 ICCS/ESCCA consensus guideline in patients with hematologic malignancy, aplastic24
Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon24
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care22
Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma21
A combination of carfilzomib, dexamethasone, and daratumumab for treatment of adult patients with relapsed/refractory multiple myeloma in two dosing regimens: once-weekly and twice-weekly20
Hematological parameters and X-ray exposure among medical radiation workers: a systematic review and meta-analysis20
Hemophagocytic lymphohistiocytosis in Egyptian children: diagnosis, treatment challenges, and outcome20
The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease20
COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis20
The expression of CD30 and its clinico-pathologic significance in peripheral T-cell lymphomas19
Managing complications secondary to Waldenström’s macroglobulinemia17
Past, present, and future of orthopedic surgery in hemophilia: looking to a world without bleeding and arthropathy in the near future17
Are myelodysplastic syndromes ready for venetoclax? Exploring future potential and considerations17
0.64630103111267